UK markets closed

Achieve Life Sciences, Inc. (SP4P.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
4.6450-0.0750 (-1.59%)
At close: 08:07AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-38,269
-29,815
-42,350
-33,152
-14,730
-
Depreciation & amortisation
233
228
236
250
255
-
Deferred income taxes
-
-
-
-
-
0
Stock-based compensation
2,986
3,439
3,270
2,187
1,286
-
Change in working capital
2,537
-778
79
1,234
-285
-
Accounts payable
-403
-1,042
799
509
-527
-
Other working capital
-31,624
-24,500
-37,569
-29,440
-13,491
-
Other non-cash items
889
2,447
1,196
41
-
-3
Net cash provided by operating activities
-31,624
-24,479
-37,569
-29,440
-13,474
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-21
-
-
-17
-53
Purchases of investments
-
-
-
0
0
-25
Sales/maturities of investments
-
-
-
0
0
5,114
Net cash used for investing activities
-
-21
0
0
-17
-
Cash flows from financing activities
Common stock issued
1,499
15,301
19,212
21,343
29,497
-
Common stock repurchased
-
-30
-
-
-
-
Other financing activities
-
-220
-47
-
-48
-
Net cash used provided by (used for) financing activities
16,510
15,278
19,315
36,610
32,680
-
Net change in cash
-15,115
-9,225
-18,251
7,169
19,189
-
Cash at beginning of period
33,362
24,821
43,072
35,903
16,714
-
Cash at end of period
18,248
15,596
24,821
43,072
35,903
-
Free cash flow
Operating cash flow
-31,624
-24,479
-37,569
-29,440
-13,474
-
Capital expenditure
-
-21
-
-
-17
-53
Free cash flow
-31,624
-24,500
-37,569
-29,440
-13,491
-